Frandol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Frandol

Property Description
Active Ingredient Isosorbide Dinitrate (ISDN)
Forms Tablets (oral, sublingual), Extended-release capsules, Injectable solution
Pharmacological Class Antianginal Agent, Vasodilator
Origin Synthetic Organic Nitrate Ester
General Purpose To reduce the heart's workload and help manage oxygen supply/demand

Frandol is a specific brand of single-ingredient prescription medication containing the active compound Isosorbide Dinitrate (ISDN). This substance is categorized chemically as a synthetic organic nitrate ester. Frandol is clinically recognized as an antianginal agent and a vasodilator, confirming its dedicated therapeutic role in affecting the cardiovascular system to provide support to the heart muscle.

Core Classification and Mechanism

The fundamental action of Frandol involves its role as a nitric oxide (NO) donor. This action signals the smooth muscle walls of veins and arteries to relax, leading to systemic vasodilation and easing the burden on the heart. This process of widening blood vessels is the key to achieving its general therapeutic purpose: to balance the heart's oxygen needs by significantly reducing its overall workload.

Frandol is offered in multiple pharmaceutical preparations, including standard oral tablets, specialized sublingual tablets for rapid absorption, and extended-release capsules for sustained effect. The availability of these distinct forms allows the medication to be administered appropriately, whether for rapid systemic action (sublingual route) or for continuous, steady therapeutic support (oral route) in adult patients.

Regulatory References

  1. Isosorbide: MedlinePlus Drug Information

What side effects are possible with Frandol?

Possible Side Effects and Safety Information

The safety profile for Frandol (Isosorbide Dinitrate) is officially documented by government regulatory agencies and is primarily defined by the medicine's vasodilatory effects. Adverse reactions are classified by frequency and system-organ class.


Adverse Reaction Classifications

Classification Examples of Reactions
Very Common Headache (often referred to as nitrate-induced headache)
Common Dizziness, Hypotension (low blood pressure), Tachycardia (increased heart rate)
Uncommon Nausea, Vomiting, Transient flushing
Very Rare Exfoliative dermatitis

Key Safety Characteristics

Adverse reactions are formally grouped, with frequent effects involving Vascular Disorders and Nervous System Disorders. Serious adverse reactions documented in regulatory sources include episodes of Syncope (fainting), Severe Hypotension, and the possibility of Circulatory Collapse.

Time-related safety patterns note that headaches are a characteristic adverse reaction that may occur at the beginning of treatment and commonly diminish with continued use. Furthermore, the potential for developing tolerance and cross-tolerance with other organic nitrates is officially noted with prolonged or continuous exposure.

Safety constraints state that Frandol is formally contraindicated in individuals with pronounced anemia or conditions associated with increased intracranial pressure. A high-level safety restriction explicitly concerns the co-administration with phosphodiesterase type 5 (PDE5) inhibitors, which is associated with a risk of severe hypotension and collapse.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Frandol (Isosorbide Dinitrate) is officially documented to result primarily from a magnification of its vasodilator effects, leading to a prompt and severe fall in blood pressure (hypotension). Manifestations described in regulatory information include persistent and throbbing headache, syncope (fainting), vertigo, and palpitations.

Life-Threatening Manifestations

System Documented Outcome
Cardiovascular Reduced cardiac output and profound systemic hypotension
Hematological Potential for Methemoglobinemia, signaled by cyanosis
Neurological Convulsions and changes in consciousness

When to Seek Immediate Medical Help

Immediate emergency medical attention is required upon the suspicion of an overdose or the manifestation of severe symptoms, such as syncope or signs of Methemoglobinemia. Management is primarily symptomatic and supportive, including efforts to increase central fluid volume with intravenous fluids and measures to facilitate venous return, such as passive elevation of the patient's legs.

Supportive procedures, including gastric lavage, may be officially considered if ingestion was recent. Treatment with Methylene Blue is specifically indicated for the complication of clinically significant Methemoglobinemia.

Therapeutic Uses of Frandol

Main Uses and Therapeutic Role

Frandol is a medication primarily indicated for the management of conditions related to coronary artery disease. It belongs to a class of drugs known as nitrates, which act on the cardiovascular system to improve blood flow and oxygen delivery to the heart muscle.

Chronic Management of Angina Pectoris

The primary use of Frandol is the long-term prevention and management of angina pectoris. Angina is characterized by chest pain or discomfort that occurs when the heart muscle does not receive an adequate supply of oxygen-rich blood. By facilitating a more consistent blood supply, the medication helps to reduce the frequency and severity of these episodes.

Ischemic Heart Disease

Frandol is utilized in the treatment of various forms of ischemic heart disease. In these conditions, narrowed or obstructed coronary arteries limit the flow of blood to the heart. The medication helps to alleviate the resulting symptoms and supports overall cardiac function in patients with chronic stability issues.

Benefits and Mechanism of Action

Vasodilation and Improved Blood Flow

The therapeutic benefits of Frandol are derived from its ability to induce vasodilation. It relaxes the smooth muscles in the walls of the blood vessels, causing them to widen. This process results in:

  • Reduced Preload: By dilating the veins, the medication reduces the volume of blood returning to the heart, which decreases the workload on the cardiac muscle.
  • Reduced Afterload: To a lesser extent, the dilation of systemic arteries reduces the resistance against which the heart must pump.
  • Enhanced Coronary Circulation: It improves the distribution of blood flow to the subendocardial layers of the heart, which are most vulnerable to oxygen deprivation.

Symptom Control and Exercise Tolerance

By optimizing the balance between myocardial oxygen supply and demand, Frandol helps patients maintain a better quality of life. This includes:

  • Reduction in Chest Pain: A decrease in the occurrence of stable angina symptoms during daily activities.
  • Increased Physical Capacity: Patients may experience an improved ability to engage in physical exertion or exercise before the onset of cardiac discomfort.

Eligibility and Restrictions for Use

Frandol (Isosorbide Dinitrate) is subject to strict eligibility rules defined by official regulatory labeling.

Populations for Whom Use is Contraindicated

Use is absolutely contraindicated in patients with a known hypersensitivity to any organic nitrate or nitrite. A primary non-eligibility rule is the concurrent use of specific medications: Frandol must not be used with Phosphodiesterase Type 5 (PDE5) inhibitors (e.g., sildenafil, tadalafil) or with the soluble guanylate cyclase stimulator riociguat. Use is also prohibited in patients experiencing acute circulatory failure, cardiogenic shock, or marked hypotension (systolic blood pressure typically le 90 mmHg).

Conditional and Restricted Eligibility

Regarding age, use is established for adults, but the safety and effectiveness have not been established in pediatric patients under 18 years of age. Caution is required for use in older adults and in patients with severe renal or hepatic impairment. Official documents also advise restriction in conditions such as severe anemia, increased intracranial pressure, and certain cardiac issues like hypertrophic cardiomyopathy.

For pregnancy and lactation, Frandol is generally not recommended unless the potential benefit is judged to outweigh the potential risk, reflecting a lack of controlled human safety data.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Frandol (Isosorbide Dinitrate) is characterized primarily by specific pharmacodynamic interactions that affect blood pressure and the cardiovascular system, as documented in regulatory prescribing information.

Absolute Contraindications

The co-administration of Frandol with two specific classes of medicinal products is strictly prohibited due to the high risk of severe, life-threatening hypotension and cardiovascular collapse. This combination is contraindicated and must be avoided.

  • Phosphodiesterase Type 5 (PDE5) Inhibitors: This includes sildenafil, vardenafil, and tadalafil. Co-use leads to a synergistic potentiation of vasodilatory effects.
  • Soluble Guanylate Cyclase (sGC) Stimulators: This includes riociguat, which also significantly amplifies the effects on the nitric oxide pathway.

Pharmacodynamic Reinforcement

Other interactions primarily involve an additive hypotensive effect (pharmacodynamic reinforcement) when Frandol is taken with other agents that lower blood pressure. The official labeling states that co-administration with other antihypertensive agents (such as beta-blockers, calcium channel blockers, ACE inhibitors, and diuretics), as well as Tricyclic Antidepressants and certain Major Tranquilizers, may increase the risk of hypotension.


Drug–Substance Interaction

Regulatory documents specify that the consumption of alcohol (ethanol) may potentiate the vasodilating and hypotensive effects of Frandol, which increases the risk of adverse cardiovascular outcomes.

No mandatory timing separation rules are documented in primary regulatory labels based on pharmacokinetic interactions with specific liver enzymes.

Mechanism of Action

How Frandol Works

Frandol's mechanism of action is centered on its ability to influence vascular tone by modifying an essential cellular signaling pathway, which results in the modulation of cardiac hemodynamic load.


Bioactivation and the Nitric Oxide Cascade

The drug requires bioactivation by the enzyme Mitochondrial Aldehyde Dehydrogenase ( ALDH2) within vascular smooth muscle cells. This process releases Nitric Oxide ( NO), a gaseous cellular messenger. NO then activates Soluble Guanylate Cyclase ( sGC), initiating the cGMP signaling pathway that ultimately governs muscle relaxation.


Modulation of Vascular Tone and Hemodynamics

The resulting surge in cGMP concentration triggers the relaxation of vascular smooth muscle cells, causing systemic vasodilation that is more pronounced in veins. This preferential venodilation reduces the volume of blood returning to the heart (Preload), while arterial widening lowers the resistance the heart pumps against (Afterload). This dual-action modulates the forces exerted on the cardiac muscle.


Mechanistic Constraint: Tolerance

The mechanism is constrained by the development of pharmacological tolerance (tachyphylaxis) upon continuous exposure. This phenomenon is often linked to the reduced activity of the ALDH2 enzyme, compromising the drug's ability to generate NO and thus diminishing the vasodilatory effect.

Dosage and Administration Information

How Frandol is Used

Frandol (Isosorbide Dinitrate) administration follows specific protocols to ensure appropriate delivery and maintain drug effectiveness over time. The medicine is available in three primary routes and forms: oral tablets (immediate-release and extended-release) for long-term use, sublingual tablets for rapid action, and an injectable solution for intravenous use, generally confined to hospital settings.

Dosing and Administration Schedules

Administration Type Dosing Pattern Principle
Oral (Immediate-Release) Typically administered 2 to 3 times a day. Initial doses range from 5 mg to 20 mg, with maintenance up to 40 mg per dose.
Oral (Extended-Release) Typically administered once or twice a day. Initial dose is generally 40 mg, with maintenance ranging from 40 mg to 80 mg (maximum 160 mg daily).
Sublingual (SL) Used as needed for acute events, typically a 2.5 mg or 5 mg dose. May be repeated every 5 to 10 minutes, not to exceed 3 doses within 15 to 30 minutes.

Procedural Requirements

For chronic oral use, the administration schedule is purposefully asymmetric to include a mandatory nitrate-free interval of approximately 14 to 18 hours daily. This specific cycle is a core instruction to prevent the development of tolerance, which would limit the drug's action over time. Extended-release forms must be swallowed whole and must not be crushed, chewed, or divided. Sublingual tablets must be placed under the tongue and allowed to dissolve completely. For specific populations, such as older adults, instructions advise initiating treatment cautiously at the lower end of the established dose range.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Frandol (Isosorbide Dinitrate)


Evidence for Managing Symptoms of Stable Angina Pectoris

Research examined Frandol in contexts involving stable angina, a condition characterized by fluctuating or episodic manifestations of chest discomfort. Studies monitored outcomes related to physical discomfort and how these changed over defined time intervals. The research typically included adult cohorts, many of whom were already receiving other established background therapies.

Studies conducted during periods of increased symptom activity reported specific measurements of how frequently angina episodes were counted per week, and also measured the duration of physical activity that participants could achieve before anginal symptoms started. Regulatory and research records describe the physiological pattern of nitrate tolerance, where a decreased measured response was observed during continuous high-frequency use in some studies. This necessitated research exploring specific “nitrate-free” intervals to understand patterns in measured responses.


Evidence for Use in Chronic Heart Failure (Reduced Ejection Fraction)

Research examined Frandol in contexts involving functional limitations due to chronic heart failure (specifically with reduced ejection fraction, HFrEF). Studies were conducted during long-term observation periods, and the research often examined it as part of a fixed-dose combination with hydralazine, not as a single agent. Key studies monitored patient follow-up and hospitalization frequencies across the study period, and also changes in the patients' ability to perform physical activity (exercise capacity).

What remains uncertain is that the majority of measured outcomes stem from trials utilizing the fixed-dose combination; therefore, the specific contributions and measured outcomes of Frandol as a monotherapy (used alone) for chronic HFrEF are not fully established.


What is Still Uncertain About Frandol Research

While research provides context, certain areas highlight what is still uncertain. Comparative evidence is lacking in some contexts, particularly head-to-head comparisons against all other medications within its class. Data for certain special populations, such as children and pregnant individuals, remain insufficient, and research findings describe group patterns and do not provide insight into individual outcomes.

Frequently Asked Questions (FAQ)

Common questions about Frandol (FAQ)


Q: What is Frandol used for exactly?

According to official drug information, Frandol (Isosorbide Dinitrate) is indicated primarily for the prevention of angina pectoris, which is chest pain caused by heart disease. It is also used as a part of treatment regimens for specific conditions like congestive heart failure.


Q: Is Frandol the same kind of medicine as [Commonly confused drug A]?

Frandol belongs to a class of medications called organic nitrates. Its action is focused on modulating vascular tone. This classification distinguishes it from other types of heart or pain medications.


Q: What are the most commonly reported side effects of Frandol?

Regulatory documents indicate that the most commonly reported side effects include headache and feelings of dizziness or lightheadedness. These effects are often noted when a person first begins treatment with the medication.


Q: Can Frandol affect my ability to drive?

Regulatory labeling states that dizziness or lightheadedness may occur. Warnings advise against driving or operating complex machinery until a person is aware of how the drug affects them.


Q: Is Frandol a type of NSAID or a steroid?

Frandol is neither an NSAID (Non-Steroidal Anti-Inflammatory Drug) nor a steroid. It is classified as an organic nitrate medicine, which functions primarily by widening the blood vessels.


Q: Is Frandol an addictive medicine?

Official warnings mention that for industrial workers with high, continuous exposure to organic nitrates, a form of physical dependence has been observed upon sudden cessation. This documented phenomenon is related to the body's physical adaptation and does not refer to abuse potential.


Q: Are there any special warnings for people with kidney problems who want to use Frandol?

Official prescribing information notes that Frandol should be used with caution in people with conditions that may cause low blood pressure, such as certain types of heart failure. Any use in patients with kidney conditions should be determined by a healthcare provider.


Q: Can Frandol cause weight gain or weight loss?

Official safety data has noted reports of unusual weight changes as an adverse event. While these events have been reported, the incidence rate of this side effect has not been established in regulatory documents.


Q: Are there any common skin reactions linked to Frandol?

Safety data includes reports of flushing (a feeling of warmth or redness) and hives. A rash is also listed as a potential reaction requiring prompt attention from a healthcare professional.


Q: Is Frandol gluten-free or does it contain lactose?

The official labeling contains a complete list of all active and inactive ingredients used in the formulation of Frandol. Consideration of specific restrictions requires reviewing this list with a healthcare provider or pharmacist.


Q: Can Frandol be used during pregnancy?

Official regulatory documents indicate that there is currently no adequate data from studies in pregnant women to assess the risk of the drug. Documentation indicates that use during pregnancy should be considered only when the potential benefit is determined to justify the potential risk.


Q: Does Frandol affect sleep?

While there is no explicit mention of insomnia or sleep loss, official safety documents list side effects such as confusion or unusual tiredness. If these effects occur, they may indirectly interfere with normal rest patterns.


Q: Is Frandol known to cause mood changes?

Official safety data lists confusion and mood or mental changes as reported adverse events. However, the exact frequency of these effects is not established in the current regulatory safety documents.


Q: What are the clinical trial findings about the benefits of Frandol?

Clinical trials reviewed by regulators have examined its effects on factors such as exercise tolerance and the frequency of anginal events, showing changes relative to placebo. Official documents state this information is based on evidence reviewed by regulatory authorities.


Q: Why is Frandol sometimes prescribed alongside another medication?

Official prescribing information indicates that Frandol is often used as part of a combination regimen with other medications. This approach is used to treat conditions like congestive heart failure in specific patient populations.


Q: Do studies show that Frandol's effects decrease over time (tolerance)?

Yes, regulatory documents confirm that the drug’s effectiveness may decrease over time, a phenomenon known as tolerance. To counter this, official administration instructions for chronic use include the requirement for a daily nitrate-free interval.


Q: Can Frandol impact the results of a standard blood test?

Official warnings advise that the medication can cause a condition called methemoglobinemia. This condition involves an abnormal change in a specific red blood cell component which is detectable by blood tests.


Q: Are there special considerations for using Frandol in different climates or elevations?

Official patient information notes that using Frandol in conditions involving hot weather or standing for long periods may increase the likelihood of dizziness, lightheadedness, or fainting due to a temporary drop in blood pressure.


Q: Are there any known interactions between Frandol and herbal supplements?

Official patient guidance recommends that a healthcare provider be informed of all prescription and non-prescription medicines, vitamins, and herbal products used. This is due to the potential for interactions that may not have been fully studied.


Q: What is the half-life of Frandol?

The half-life refers to the time it takes for half of the active drug to be cleared from the bloodstream. For the active ingredient, Isosorbide Dinitrate, the half-life in serum is approximately one hour.


Q: Does Frandol contain any ingredients that could trigger an allergic reaction?

Frandol is strictly contraindicated for anyone with a known allergy to the active substance (Isosorbide Dinitrate) or to any of the inactive ingredients listed in the product formulation.


Q: Is it normal to have a slight headache when first starting Frandol?

Yes, a daily headache often accompanies treatment, particularly when initiating the medication. This common side effect has been noted in official patient information as a frequent accompaniment to treatment initiation.


Q: How is Frandol disposed of safely?

Standard regulatory disposal advice is to keep the medication tightly closed and secure. Disposal methods include using official drug take-back programs. Information on proper disposal of prescription medications is available from the FDA.


Q: What is the current storage recommendation for Frandol?

Regulatory guidance advises that Frandol should be stored at room temperature. It is important to keep the medication away from excess heat, direct sunlight, and moisture to ensure its stability.


Q: How long does it typically take for Frandol to start working?

The onset of action depends on the form used. Sublingual tablets are designed for rapid action during acute events, while oral forms are intended to provide an effect over time for long-term prevention.


Q: How long does the effect of one dose of Frandol typically last?

The duration of effect is formulation-dependent. The anti-anginal activity for the oral forms is sustained, and the required nitrate-free interval in the dosing schedule indicates that the effect lasts less than a full 24-hour cycle.


Q: Does Frandol interact with common medications like paracetamol or ibuprofen?

Regulatory-backed patient information indicates that the use of paracetamol with Frandol is usually permissible. However, for non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, specific review by a healthcare provider is noted due to potential considerations with underlying conditions.


Q: Why is Frandol prescribed for [Condition X] but not [Condition Y]?

The prescription of Frandol is determined by regulatory-approved indications, primarily for the prevention of angina and as an adjunct treatment for heart failure. It is prescribed for these conditions because clinical evidence supports its use for them.


Q: Is it common to feel dizzy after starting Frandol?

Yes, feeling dizzy or lightheaded is a commonly reported side effect. This is related to the drug's intended action of widening blood vessels, which can lead to a temporary drop in blood pressure.


Q: What happens if I accidentally take too much Frandol?

Overdose symptoms can include a severe throbbing headache, confusion, severe dizziness, or an irregular heartbeat. Official information states that any signs of overdose necessitate prompt medical intervention.

How should Frandol be stored and disposed of?

How to Store and Dispose of Frandol

Frandol (Isosorbide Dinitrate) must be stored under specific regulatory conditions to maintain stability and effectiveness.


Storage Requirements

The medicine must be stored at controlled room temperature (20 C to 25 C), protected from both light and moisture. Regulatory labeling explicitly states to keep the container tightly closed and do not freeze the product. Sublingual forms require storage in their original glass container to prevent documented loss of potency. All forms of the medication must be kept out of the sight and reach of children.


Official Disposal Instructions

Disposal of unused or expired Frandol must follow regulatory guidelines. The preferred method is using local drug take-back programs. If household disposal is necessary, the medicine must be mixed with an undesirable substance (e.g., dirt, used coffee grounds) and placed in a sealed container before discarding. The product should not be flushed down the toilet unless explicitly instructed by the labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Frandol found in:

A-Z Index: